France Infectious Diseases: Sales and Volume Segment Forecasts for 100 Tests, Supplier Shares by Test, Innovative Technologies, Competitive Strategies, Emerging Opportunities

Publisher Name :
Date: 30-Sep-2016
No. of pages: 890

Complete report $6,700.  DataPack (test volumes, sales forecasts, supplier shares) $4,300.

VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key French market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
 
Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.  

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation,
  reagents kits, IT and other products with significant market
  appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

- Sales and market shares of major suppliers
  by individual test.

- Volume and sales forecasts for over 100 infectious disease
   assays by individual test and market segment:

     ° Hospitals
     ° Blood Banks
     ° Commercial/Private Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics,
   culture/microscopy).

- Review of the market dynamics, trends,
  structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of over 100 major diseases,
  including their etiology, current diagnostic tests,
  vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
  testing, including their operating
  characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,
  immunoassay, and other technologies and their potential
  applications for infectious disease testing.

- Global listings of companies developing or
  marketing infectious disease diagnostic products
  by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
  emerging market entrants, including their sales, product
  portfolios, marketing tactics, collaborative
  arrangements and new products in R&D.

Contains 890 pages and 160 tables
 

France Infectious Diseases: Sales and Volume Segment Forecasts for 100 Tests, Supplier Shares by Test, Innovative Technologies, Competitive Strategies, Emerging Opportunities

Table of Contents

I. Introduction
II. Worldwide Market Overview
A. Business Environment
B. Market Structure
C. Market Size and Growth
III. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. Worldwide Overview of Major Tests, Technologies, and Instrumentation
A. Major Infectious Disease Tests
1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
2. Adenovirus 3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter 11. Candida 12. Chagas Disease
13. Chancroid 14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakob's Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori
33. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies 53. Respiratory Syncytial Virus (RSV)
54. Rhinoviruses
55. Rotavirus
56. Rubella
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Infectious Disease Automated and Semiautomated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
VIII. France Infectious Disease Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
IX. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List of Tables

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
France Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast By Market Segment
France Laboratories Performing Infectious Disease Tests by Market Segment
France Hospital Laboratories Performing Infectious Disease Tests by Bed Size
France Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
France All Market Segments Infectious Disease Test Volume Forecast
France All Market Segments Infectious Disease Test Volume by Method
France Hospital Laboratories Infectious Disease Test Volume Forecast
France Blood Banks Infectious Disease Test Volume Forecast
France Commercial/Private Laboratories Infectious Disease Test Volume Forecast
France All Market Segments Infectious Disease Diagnostics Market Forecast
France Hospital Laboratories Infectious Disease Diagnostics Market Forecast
France Blood Banks Infectious Disease Diagnostics Market Forecast
France Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
France HIV/HIV-1/2/Combo, Test Volume and Diagnostics Sales Forecast By Market Segment
France HIV Ag Test Volume and Diagnostics Sales Forecast By Market Segment
France Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
France Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
France BEA Test Volume and Diagnostics Sales Forecast by Market Segment
France Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
France Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
France Candida Test Volume and Diagnostics Sales Forecast by Market Segment
France Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Test Volume and Diagnostics Sales Forecast By Market Segment
France Clostridium Test Volume and Diagnostics Sales Forecast By Market Segment
France Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Coxsackievirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Cryptosporidium Test Volume and Diagnostics Sales Forecast By Market Segment
France CMV Test Volume and Diagnostics Sales Forecast by Market Segment
France Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
France E. Coli Test Volume and Diagnostics Sales Forecast By Market Segment
France Echovirus Test Volume and Diagnostics Sales Forecast By Market Segment
France Encephalitis Test Volume and Diagnostics Sales Forecast By Market Segment
France Enterovirus Test Volume and Diagnostics Sales Forecast By Market Segment
France EBV Test Volume and Diagnostics Sales Forecast by Market Segment
France Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
France Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
France Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
France Hantavirus Test Volume and Diagnostics Sales Forecast By Market Segment
France Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
France HBsAg Test Volume and Diagnostics Sales Forecast By Market Segment
France HCV Test Volume and Diagnostics Sales Forecast By Market Segment
France HCV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
France Hepatitis C Test Volume and Diagnostics Sales Forecast By Market Segment
France Anti-HBc Test Volume and Diagnostics Sales Forecast By Market Segment
France Anti-HBs Test Volume and Diagnostics Sales Forecast By Market Segment
France Anti-HAV Test Volume and Diagnostics Sales Forecast By Market Segment
France Hepatitis Delta Test Volume and Diagnostics Sales Forecast By Market Segment
France HAV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
France HBV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
France HBcAg Test Volume and Diagnostics Sales Forecast By Market Segment
France HBeAg Test Volume and Diagnostics Sales Forecast By Market Segment
France ALT/SGPT Test Volume and Diagnostics Sales Forecast By Market Segment
France Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
France Herpes Type VI Test Volume and Diagnostics Sales Forecast By Market Segment
France HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
France Influenza Test Volume and Diagnostics Sales Forecast By Market Segment
France Legionella Test Volume and Diagnostics Sales Forecast By Market Segment
France Lyme Disease Test Volume and Diagnostics Sales Forecast By Market Segment
France Lymphogranuloma Test Volume and Diagnostics Sales Forecast By Market Segment
France Malaria Test Volume and Diagnostics Sales Forecast By Market Segment
France Measles Test Volume and Diagnostics Sales Forecast By Market Segment
France Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
France Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
France Mononucleosis Test Volume and Diagnostics Sales Forecast By Market Segment
France Mumps Test Volume and Diagnostics Sales Forecast By Market Segment
France Mycoplasma Test Volume and Diagnostics Sales Forecast By Market Segment
France Papilloma Virus Test Volume and Diagnostics Sales Forecast By Market Segment
France Parvovirus Test Volume and Diagnostics Sales Forecast By Market Segment
France Pneumonia Test Volume and Diagnostics Sales Forecast By Market Segment
France Polyoma Viruses Test Volume and Diagnostics Sales Forecast By Market Segment
France Pseudomonas Test Volume and Diagnostics Sales Forecast By Market Segment
France Rabies Test Volume and Diagnostics Sales Forecast By Market Segment
France RSV Test Volume and Diagnostics Sales Forecast By Market Segment
France Rhinovirus Test Volume and Diagnostics Sales Forecast By Market Segment
France Rotavirus Test Volume and Diagnostics Sales Forecast By Market Segment
France Rubella Test Volume and Diagnostics Sales Forecast By Market Segment
France Salmonella Test Volume and Diagnostics Sales Forecast By Market Segment
France Septicemia Test Volume and Diagnostics Sales Forecast By Market Segment
France Shigella Test Volume and Diagnostics Sales Forecast By Market Segment
France Staphylococci Test Volume and Diagnostics Sales Forecast By Market Segment
France Streptococci Test Volume and Diagnostics Sales Forecast By Market Segment
France Syphilis Test Volume and Diagnostics Sales Forecast By Market Segment
France Toxoplasmosis Test Volume and Diagnostics Sales Forecast By Market Segment
France Trichomonas Test Volume and Diagnostics Sales Forecast By Market Segment
France Tuberculosis Test Volume and Diagnostics Sales Forecast By Market Segment
France Vibrio Test Volume and Diagnostics Sales Forecast By Market Segment
France Yersinia Test Volume and Diagnostics Sales Forecast By Market Segment
France AIDS Testing Market Diagnostics Sales By Major Supplier
France Adenovirus Testing Market Diagnostics Sales By Major Supplier
France Campylobacter Testing Market Diagnostics Sales By Major Supplier
France Candida Testing Market Diagnostics Sales by Major Supplier
France Chlamydia Testing Market Diagnostics Sales by Major Supplier
France CMV Testing Market Diagnostics Sales by Major Supplier
France Gonorrhea Testing Market Diagnostics Sales by Major Supplier
France Hepatitis Testing Market Diagnostics Sales by Major Supplier
France Hepatitis C Testing Market Diagnostics Sales By Major Supplier
France Herpes Testing Market Diagnostics Sales by Major Supplier
France Lyme Disease Testing Market Diagnostics Sales By Major Supplier
France Influenza Testing Market Diagnostics Sales By Major Supplier
France Meningitis Testing Market Diagnostics Sales By Major Supplier
France Mononucleosis Testing Market Diagnostics Sales By Major Supplier
France Mumps Testing Market Diagnostics Sales by Major Supplier
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
France RSV Testing Market Diagnostics Sales by Major Supplier
France Rotavirus Testing Market Diagnostics Sales by Major Supplier
France Rubella Testing Market Diagnostics Sales by Major Supplier
France Septicemia Testing Market Diagnostics Sales by Major Supplier
France Shigella Testing Market Diagnostics Sales by Major Supplier
France Streptococci Testing Market Diagnostics Sales by Major Supplier
France Syphilis Testing Market Diagnostics Sales by Major Supplier
France Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
France Trichomonas Testing Market Diagnostics Sales by Major Supplier
France Tuberculosis Testing Market Diagnostics Sales by Major Supplier
  • Global Point-of-Care Diagnostics Market Research Report 2017
    Published: 16-Aug-2017        Price: US 2900 Onwards        Pages: 114
    In this report, the global Point-of-Care Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Point-of-Care Diagnostics in these regions, from 2012 to 2022 (forecast), covering - North America - Europe ......
  • United States Viral Disease Diagnosis Market Report 2017
    Published: 15-Aug-2017        Price: US 3800 Onwards        Pages: 97
    In this report, the United States Viral Disease Diagnosis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of ......
  • Global Viral Disease Diagnosis Sales Market Report 2017
    Published: 10-Aug-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the global Viral Disease Diagnosis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Viral Disease Diagnosis for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global POC Diagnostics Market Size, Status and Forecast 2022
    Published: 09-Aug-2017        Price: US 3300 Onwards        Pages: 103
    This report studies the global POC Diagnostics market, analyzes and researches the POC Diagnostics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Alere - Roche - Abbott Laboratories - Johnson & Johnson - Siemens Healthcare - Danaher - Bayer Healthcare - Beckman Coulter - Nipro Diagnostics - Bio-Rad Laboratories......
  • Global Viral Disease Diagnosis Market Research Report 2017
    Published: 03-Aug-2017        Price: US 2900 Onwards        Pages: 106
    In this report, the global Viral Disease Diagnosis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Viral Disease Diagnosis in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - Ch......
  • Global Influenza Diagnostics Market Research Report 2017
    Published: 31-Jul-2017        Price: US 2900 Onwards        Pages: 116
    In this report, the global Influenza Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Influenza Diagnostics in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • Point-of-Care Diagnostics Market Global Briefing 2017 Including: Glucose And Cardiometabolic Monitoring Kits, Infectious Diseases Testing Kits, Cardiac And Cancer Markers. Covering: Alere, Abbott Diagnostics, Siemens Healthcare, Philips Healthcare, Roche Diagnostics, Danaher Corporation (Beckman Coulter), BioMerieux
    Published: 27-Jul-2017        Price: US 1000 Onwards        Pages: 35
    The global point-of-care diagnostics market was estimated to be around $20.2 billion as of 2016. The global point-of-care diagnostics made up around 34% of the overall in-vitro diagnostics market in 2016. The point-of-care diagnostics market was the largest market in the global in-vitro diagnostics market in 2016. Point-of-Care Diagnostics Market Global Briefing 2017 from The Business Research Company provides the strategists, marketers and senior management with the critical info......
  • Global POC Diagnostics Market 2017-2021
    Published: 05-Jul-2017        Price: US 3500 Onwards        Pages: 117
    POC diagnostic tests help in reducing the time between diagnosis and treatment of a disease. These tests are either antibody-based or microbial particle-based. Healthcare professionals or nurses collect the testing samples from the patient, perform analysis, and record the result. These tests include enzyme-linked immunosorbent assay (ELISA), agglutination tests, and lateral flow immunochromatography. In 2016, the global POC diagnostics market held 13.09% of the global IVD market. The......
  • Dengue Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017
    Published: 01-Jul-2017        Price: US 2500 Onwards        Pages: 78
    Dengue Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, "Dengue Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Dengue Virus Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews majo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs